Decreased hydrocortisone sensitivity of T cell function in multiple sclerosis-associated major depression

Psychoneuroendocrinology

Volumn 37, Issue 10, 2012, Pages 1712-1718

  Fischer, Anja ^a   Otte, Christian ^b   Krieger, Thorsten ^a   Nicholls, Robert A ^c   Krüger, Schulamith ^a   Ziegler, Kristin J ^a   Schulz, Karl Heinz ^a   Heesen, Christoph ^a   Gold, Stefan M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Cortisol; Depression; Hypothalamic pituitary adrenal axis; Mineralocorticoid receptor; Multiple sclerosis; Steroid resistance

Indexed keywords

ALDOSTERONE; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; MINERALOCORTICOID RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; HORMONAL REGULATION; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; HYDROCORTISONE SENSITIVITY; IMMUNE SYSTEM; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MAJOR DEPRESSION; MULTIPLE SCLEROSIS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ADULT; ALDOSTERONE; ANTI-INFLAMMATORY AGENTS; CELL PROLIFERATION; CELLS, CULTURED; DEPRESSIVE DISORDER, MAJOR; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; HUMANS; HYDROCORTISONE; IMMUNOPHENOTYPING; MULTIPLE SCLEROSIS; T-LYMPHOCYTES;

EID: 84865556809     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2012.03.001     Document Type: Article

References (35)

1. Aktas O., Hartung H.P. Beyond axonal transection: hippocampal damage in multiple sclerosis. Ann. Neurol. 2011, 69:433-436.
2. Anacker C., Zunszain P.A., Carvalho L.A., Pariante C.M. The glucocorticoid receptor: pivot of depression and of antidepressant treatment?. Psychoneuroendocrinology 2011, 36:415-425.
3. Armanini D., Endres S., Kuhnle U., Weber P.C. Parallel determination of mineralocorticoid and glucocorticoid receptors in T- and B-lymphocytes of human spleen. Acta Endocrinol. (Copenh.) 1988, 118:479-482.
4. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961, 4:561-571.
5. Chapman K.E., Coutinho A.E., Gray M., Gilmour J.S., Savill J.S., Seckl J.R. The role and regulation of 11beta-hydroxysteroid dehydrogenase type 1 in the inflammatory response. Mol. Cell. Endocrinol. 2009, 301:123-131.
6. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
7. de Kloet E.R., Derijk R.H., Meijer O.C. Therapy insight: is there an imbalanced response of mineralocorticoid and glucocorticoid receptors in depression?. Nat. Clin. Pract. Endocrinol. Metab. 2007, 3:168-179.
8. DeRijk R.H., Schaaf M., de Kloet E.R. Glucocorticoid receptor variants: clinical implications. J. Steroid Biochem. Mol. Biol. 2002, 81:103-122.
9. Diederich S., Eigendorff E., Burkhardt P., Quinkler M., Bumke-Vogt C., Rochel M., Seidelmann D., Esperling P., Oelkers W., Bahr V. 11beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids. J. Clin. Endocrinol. Metab. 2002, 87:5695-5701.
10. Fassbender K., Schmidt R., Mossner R., Kischka U., Kuhnen J., Schwartz A., Hennerici M. Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation. Arch. Neurol. 1998, 55:66-72.
11. Gold S.M., Kern K.C., O'Connor M.F., Montag M.J., Kim A., Yoo Y.S., Giesser B.S., Sicotte N.L. Smaller cornu ammonis 2-3/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms. Biol. Psychiatry 2010, 68:553-559.
12. Gold S.M., Kruger S., Ziegler K.J., Krieger T., Schulz K.H., Otte C., Heesen C. Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression. J. Neurol. Neurosurg. Psychiatry 2011, 82:814-818.
13. Gold S.M., Mohr D.C., Huitinga I., Flachenecker P., Sternberg E.M., Heesen C. The role of stress-response systems for the pathogenesis and progression of MS. Trends Immunol. 2005, 26:644-652.
14. Heesen C., Gold S.M., Huitinga I., Reul J.M. Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis-a review. Psychoneuroendocrinology 2007, 32:604-618.
15. Heidbrink C., Hausler S.F., Buttmann M., Ossadnik M., Strik H.M., Keller A., Buck D., Verbraak E., van Meurs M., Krockenberger M., Mehling M., Mittelbronn M., Laman J.D., Wiendl H., Wischhusen J. Reduced cortisol levels in cerebrospinal fluid and differential distribution of 11beta-hydroxysteroid dehydrogenases in multiple sclerosis: implications for lesion pathogenesis. Brain Behav. Immun. 2010, 24:975-984.
16. Kellner M., Wiedemann K. Mineralocorticoid receptors in brain, in health and disease: possibilities for new pharmacotherapy. Eur. J. Pharmacol. 2008, 583:372-378.
17. Kern S., Schultheiss T., Schneider H., Schrempf W., Reichmann H., Ziemssen T. Circadian cortisol, depressive symptoms and neurological impairment in early multiple sclerosis. Psychoneuroendocrinology 2011, 36:1505-1512.
18. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33:1444-1452.
19. Macqueen G., Frodl T. The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research?. Mol. Psychiatry 2011, 16:252-264.
20. Miller A.H. Depression and immunity: a role for T cells?. Brain Behav. Immun. 2010, 24:1-8.
21. Pace T.W., Miller A.H. Cytokines and glucocorticoid receptor signaling. Relevance to major depression. Ann. N.Y. Acad. Sci. 2009, 1179:86-105.
22. Pariante C.M., Lightman S.L. The HPA axis in major depression: classical theories and new developments. Trends Neurosci. 2008, 31:464-468.
23. Patten S.B., Beck C.A., Williams J.V., Barbui C., Metz L.M. Major depression in multiple sclerosis: a population-based perspective. Neurology 2003, 61:1524-1527.
24. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 1983, 13:227-231.
25. Rupprecht R., Reul J.M., van Steensel B., Spengler D., Soder M., Berning B., Holsboer F., Damm K. Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands. Eur. J. Pharmacol. 1993, 247:145-154.
26. Schmidt M., Weidler C., Naumann H., Anders S., Scholmerich J., Straub R.H. Reduced capacity for the reactivation of glucocorticoids in rheumatoid arthritis synovial cells: possible role of the sympathetic nervous system?. Arthritis Rheum. 2005, 52:1711-1720.
27. Seckl J.R., Dickson K.L., Yates C., Fink G. Distribution of glucocorticoid and mineralocorticoid receptor messenger RNA expression in human postmortem hippocampus. Brain Res. 1991, 561:332-337.
28. Siegert R.J., Abernethy D.A. Depression in multiple sclerosis: a review. J. Neurol. Neurosurg. Psychiatry 2005, 76:469-475.
29. Sospedra M., Martin R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 2005, 23:683-747.
30. Tomlinson J.W., Walker E.A., Bujalska I.J., Draper N., Lavery G.G., Cooper M.S., Hewison M., Stewart P.M. 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr. Rev. 2004, 25:831-866.
31. van Winsen L.L., Hooper-van Veen T., van Rossum E.F., Polman C.H., van den Berg T.K., Koper J.W., Uitdehaag B.M. The impact of glucocorticoid receptor gene polymorphisms on glucocorticoid sensitivity is outweighted in patients with multiple sclerosis. J. Neuroimmunol. 2005, 167:150-156.
32. van Winsen L.M., Muris D.F., Polman C.H., Dijkstra C.D., van den Berg T.K., Uitdehaag B.M. Sensitivity to glucocorticoids is decreased in relapsing remitting multiple sclerosis. J. Clin. Endocrinol. Metab. 2005, 90:734-740.
33. Wehling M., Armanini D., Strasser T., Weber P.C. Effect of aldosterone on sodium and potassium concentrations in human mononuclear leukocytes. Am. J. Physiol. 1987, 252:E505-E510.
34. Ysrraelit M.C., Gaitan M.I., Lopez A.S., Correale J. Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis. Neurology 2008, 71:1948-1954.
35. Zunszain P.A., Anacker C., Cattaneo A., Carvalho L.A., Pariante C.M. Glucocorticoids, cytokines and brain abnormalities in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:722-729.